213 related articles for article (PubMed ID: 20197141)
1. The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy.
La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Ricciardi W
Vaccine; 2010 Apr; 28(19):3379-84. PubMed ID: 20197141
[TBL] [Abstract][Full Text] [Related]
2. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
3. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
Lee FH; Paz-Soldan VA; Carcamo C; Garcia PJ
J Low Genit Tract Dis; 2010 Apr; 14(2):113-7. PubMed ID: 20354419
[TBL] [Abstract][Full Text] [Related]
4. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
5. [Methodological aspects of clinical and economic impact of vaccine interventions and HTA. Focus on HPV vaccination].
Ricciardi W; Dirodi B; Bonanni P; Capri S; Castiglia P; Gabutti G; Gasparini R; Giorgi Rossi P; Grilli G; La Torre G
Ann Ig; 2011; 23(5):419-34. PubMed ID: 22403995
[TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus vaccination: perceptions of young Korean women.
Kang HS; Shin H; Hyun MS; Kim MJ
J Adv Nurs; 2010 Sep; 66(9):1946-52. PubMed ID: 20626486
[TBL] [Abstract][Full Text] [Related]
7. Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination.
Medeiros R; Ramada D
Vaccine; 2010 Dec; 29(2):153-60. PubMed ID: 21055494
[TBL] [Abstract][Full Text] [Related]
8. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
Mennini FS; Giorgi Rossi P; Palazzo F; Largeron N
Gynecol Oncol; 2009 Feb; 112(2):370-6. PubMed ID: 19041125
[TBL] [Abstract][Full Text] [Related]
9. One in four California adolescent girls have had human papillomavirus vaccination.
Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
[No Abstract] [Full Text] [Related]
10. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
Thomas TL
Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
[TBL] [Abstract][Full Text] [Related]
11. Current acceptance of the HPV vaccine.
Miller MM; Wilson JM; Waldrop J
Nurse Pract; 2008 Apr; 33(4):18-22; quiz 22-3. PubMed ID: 18388548
[No Abstract] [Full Text] [Related]
12. Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women.
Charakorn C; Rattanasiri S; Lertkhachonsuk AA; Thanapprapasr D; Chittithaworn S; Wilailak S
Asia Pac J Clin Oncol; 2011 Jun; 7(2):160-7. PubMed ID: 21585696
[TBL] [Abstract][Full Text] [Related]
13. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].
Sopracordevole F; Cigolot F; Lucia E; Marchesoni D
Minerva Ginecol; 2009 Apr; 61(2):81-7. PubMed ID: 19255555
[TBL] [Abstract][Full Text] [Related]
14. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
15. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
16. The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.
Sinanovic E; Moodley J; Barone MA; Mall S; Cleary S; Harries J
Vaccine; 2009 Oct; 27(44):6196-202. PubMed ID: 19698807
[TBL] [Abstract][Full Text] [Related]
17. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
[TBL] [Abstract][Full Text] [Related]
18. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
19. A brief history of economic evaluation for human papillomavirus vaccination policy.
Beutels P; Jit M
Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
[TBL] [Abstract][Full Text] [Related]
20. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
